Cargando…
晚期NSCLC患者血清EGFR基因突变状态的测定及意义
BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) has shown a high response rate in the treatment of lung cancer in patients with (EGFR) mutation. The aim of this study is to evaluate the relationship between EGFR mutation status in serum and predictin...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000571/ https://www.ncbi.nlm.nih.gov/pubmed/23769345 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.06.06 |